Astellas Pharma Receivables 2012-2024 | ALPMY

Astellas Pharma receivables for the quarter ending June 30, 2024 were $3.840B, a 9.58% increase year-over-year.

  • Astellas Pharma receivables for 2024 were $3.629B, a 8.26% increase from 2023.
  • Astellas Pharma receivables for 2023 were $3.352B, a 1.21% increase from 2022.
  • Astellas Pharma receivables for 2022 were $3.312B, a 2.92% increase from 2021.

Astellas Pharma Receivables 2012-2024 | ALPMY

  • Astellas Pharma receivables for 2024 were $3.629B, a 8.26% increase from 2023.
  • Astellas Pharma receivables for 2023 were $3.352B, a 1.21% increase from 2022.
  • Astellas Pharma receivables for 2022 were $3.312B, a 2.92% increase from 2021.